XML 40 R26.htm IDEA: XBRL DOCUMENT v3.7.0.1
Organization, Nature of Operations and Basis of Presentation (Tables)
 12 Months Ended
Dec. 31, 2016
Organization, Nature of Operations and Basis of Presentation [Abstract]  
Schedule of Multi Clinic Acquisition
During 2016, 2015 and 2014, the Company completed the following multi-clinic acquisitions of physical therapy practices:

 
Date   
% Interest Acquired
  
Number of Clinics
 
         
 
2016       
February 2016 Acquisition
February  29
   
55
%
  
8
 
November 2016 Acquisition
November 30
   
60
%
  
12
 
           
 2015
         
January 2015 Acquisition
January 31
   
60
%
  
9
 
April 2015 Acquisition
April 30
   
70
%
  
3
 
June 2015 Acquisition
June 30
   
70
%
  
4
 
December 2015 Acquisition
December 31
   
59
%
  
4
 
           
 
2014         
April 2014 Acquisition
April 30
   
70
%
  
13
 
August 2014 Acquisition
August 1
   
100
%
  
3
 
Consolidated Balance Sheet
Consolidated Balance Sheet on December 31, 2015:

Description
 
As Reported
  
Adjustment
  
As Restated
 
Goodwill
 
$
171,457
  
$
23,916
  
$
195,373
 
Total assets
 
$
279,913
  
$
23,844
  
$
303,757
 
MRNCI (1)
  
-
  
$
45,974
  
$
45,974
 
Deferred taxes (liability)
 
$
8,355
  
$
7,153
  
$
15,508
 
Total liabilities
 
$
77,960
  
$
53,487
  
$
131,447
 
RNCI (2)
 
$
8,843
  
$
(8,843
)
  
-
 
Additional paid-in capital
 
$
45,251
  
$
18,987
  
$
64,238
 
Retained earnings
 
$
149,016
  
$
(10,715
)
 
$
138,301
 
Total liabilities and equity
 
$
279,913
  
$
23,844
  
$
303,757
 

(1)
Mandatorily redeemable non-controlling interests
(2)
Redeemable non-controlling interests
Consolidated Statement of Net Income
Consolidated Statement of Net Income for the Year Ended December 31, 2015:
 
Description
 
As Reported
  
Adjustment
  
As Restated
 
Interest expense
         
MRNCI (1) – changes in redemption value
  
-
  
$
2,670
  
$
2,670
 
MRNCI (1) – earnings allocable
  
-
  
$
3,538
  
$
3,538
 
Total interest expense
 
$
1,031
  
$
6,208
  
$
7,239
 
Net income before taxes
 
$
46,344
  
$
(6,208
)
 
$
40,136
 
Provision for income taxes
 
$
14,653
  
$
(1,006
)
 
$
13,647
 
Net income
 
$
31,691
  
$
(5,202
)
 
$
26,489
 
Less: net income attributable to non-controlling interests
 
$
9,412
  
$
(3,538
)
 
$
5,874
 
Net income attributable to USPH shareholders
 
$
22,279
  
$
(1,664
)
 
$
20,615
 
Earnings per share
 
$
1.77
  
$
(0.11
)
 
$
1.66
 

(1)
See above.

Consolidated Statement of Net Income for the Year Ended December 31, 2014:

Description
 
As Reported
  
Adjustment
  
As Restated
 
Interest expense
         
MRNCI (1) – change in redemption value
  
-
  
$
2,978
  
$
2,978
 
MRNCI (1) – earnings allocable
  
-
  
$
3,388
  
$
3,388
 
Total interest expense
 
$
1,088
  
$
6,366
  
$
7,454
 
Net income before taxes
 
$
44,698
  
$
(6,366
)
 
$
38,332
 
Provision for income taxes
 
$
14,274
  
$
(1,256
)
 
$
13,018
 
Net income
 
$
30,424
  
$
(5,110
)
 
$
25,314
 
Less: net income attributable to non-controlling interests
 
$
9,571
  
$
(3,388
)
 
$
6,183
 
Net income attributable to USPH shareholders
 
$
20,853
  
$
(1,722
)
 
$
19,131
 
Earnings per share
 
$
1.62
  
$
(0.05
)
 
$
1.57
 

 (1)
See above.
Consolidated Statement of Cash Flows
Consolidated Statement of Cash Flows for the Year Ended December 31, 2015:

Description
 
As Reported
  
Adjustment
  
As Restated
 
Net income
 
$
31,691
  
$
(5,202
)
 
$
26,489
 
Deferred taxes
 
$
7,001
  
$
(1,048
)
 
$
5,953
 
(Increase) decrease in other assets
 
$
(1,477
)
 
$
102
  
$
(1,375
)
(Decrease) increase in accounts payable and accrued expenses
 
$
(7,013
)
 
$
2
  
$
(7,011
)
Increase in mandatorily redeemable non-controlling interest
 
$
-
  
$
2,509
  
$
2,509
 
(Decrease) increase in other liabilities
 
$
1,482
  
$
(86
)
 
$
1,396
 
Net cash provided by operating activities
 
$
41,243
  
$
(3,723
)
 
$
37,520
 
Acquisitions of non-controlling interests
 
$
(7,083
)
 
$
6,115
  
$
(968
)
Net cash used in investing activities
 
$
(32,240
)
 
$
6,115
  
$
(26,125
)
Distributions to non-controlling interests (including redeemable non-controlling interests)
 
$
(9,632
)
 
$
9,632
  
$
-
 
Distributions to non-controlling interests
 
$
-
  
$
(5,892
)
 
$
(5,892
) 
Payments to settle mandatorily redeemable non-controlling interests
 
$
-
  
$
(6,115
)
 
$
(6,115
)
Other
 
$
22
  
$
(17
)
 
$
5
 
Net cash used in financing activities
 
$
(7,496
)
 
$
(2,392
)
 
$
(9,888
)
 
Consolidated Statement of Cash Flows for the Year Ended December 31, 2014:

Description
 
As Reported
  
Adjustment
  
As Restated
 
Net income
 
$
30,424
  
$
(5,110
)
 
$
25,314
 
Deferred taxes
 
$
6,275
  
$
(1,169
)
 
$
5,106
 
(Increase) decrease in other assets
 
$
(2,493
)
 
$
3,648
  
$
1,155
 
Increase in mandatorily redeemable non-controlling interest
 
$
-
  
$
2,936
  
$
2,936
 
(Decrease) increase in other liabilities
 
$
730
  
$
(4,108
)
 
$
(3,378
)
Net cash provided by operating activities
 
$
45,194
  
$
(3,803
)
 
$
41,391
 
Acquisitions of non-controlling interests
 
$
(5,490
)
 
$
5,263
  
$
(227
)
Net cash used in investing activities
 
$
(22,880
)
 
$
5,263
  
$
(17,617
)
Distributions to non-controlling interests (including redeemable non-controlling interests)
 
$
(9,913
)
 
$
9,913
  
$
-
 
Distributions to non-controlling interests
 
$
-
  
$
(5,963
)
 
$
(5,963
) 
Payments to settle mandatorily redeemable non-controlling interests
 
$
-
  
$
(5,233
)
 
$
(5,233
)
Other
 
$
222
  
$
(177
)
 
$
45
 
Net cash used in financing activities
 
$
(20,941
)
 
$
(1,460
)
 
$
(22,401
)